Negative Impact of Vapes on Public Health: WHO Calls for Urgent Action

Regulations by 2FIRSTS.ai
Dec.22.2023
Negative Impact of Vapes on Public Health: WHO Calls for Urgent Action
World Health Organization (WHO) states that there is no evidence that e-cigarettes effectively help smokers quit. Instead, evidence shows negative impacts on public health.

The World Health Organization (WHO) categorically states that there is no evidence to suggest that e-cigarettes can effectively assist community smokers in quitting smoking. On the contrary, there is existing evidence that indicates e-cigarettes have a negative impact on public health.

 

E-cigarettes have been widely available on the market and extensively promoted among young people. Currently, 34 countries have implemented bans on the sales of e-cigarettes, while 88 countries lack any minimum age restrictions for purchasing e-cigarettes. Additionally, 74 countries have no regulations in place regarding these harmful products.

 

World Health Organization Director-General Tedros Adhanom Ghebreyesus emphasized that "children are being lured into smoking and may become addicted to nicotine at a young age. I urge countries to implement strict measures to prevent the use of e-cigarettes in order to protect their citizens, especially children and adolescents.

 

E-cigarettes, which contain highly addictive nicotine, are harmful to health. While we have not yet fully understood their long-term effects on health, it has been established that they produce harmful substances, some of which are considered carcinogens, while others increase the risk of heart and lung diseases. The use of e-cigarettes may also affect brain development, leading to learning and cognitive impairments in young people. Pregnant women exposed to e-cigarettes may have adverse effects on the development of the fetus. The toxic gases in e-cigarettes also pose risks to those around the users.

 

The usage of e-cigarettes among children aged 13-15 is reported in all regions of the World Health Organization. In Canada, the prevalence of e-cigarette use among individuals aged 16-19 has doubled between 2017 and 2022. Similarly, in the UK, the number of teenagers using e-cigarettes has tripled in the past three years.

 

Research consistently indicates that even brief exposure to social media content about e-cigarettes can potentially increase both the willingness to use these products and the positive attitude towards e-cigarettes. Young people who use e-cigarettes are nearly three times more likely to use traditional cigarettes in the future.

 

The World Health Organization (WHO) has called on countries to take urgent measures to prevent the use of e-cigarettes and nicotine addiction, as well as to implement comprehensive tobacco control methods that align with each country's respective circumstances. In countries where the sale of e-cigarettes is prohibited, the WHO urges stronger enforcement of such bans and continuous monitoring to support public health interventions and ensure strict compliance. In countries where the sale of e-cigarettes as consumer products (including sales, imports, distribution, and production) is permitted, the WHO emphasizes the need for strict regulations to reduce their attractiveness and harm to the public. This includes the prohibition of all flavors, limitations on nicotine concentration and content, as well as taxation.

 

The strategy for smoking cessation should be based on the best available evidence and should be accompanied by other tobacco control measures, and it should be monitored and evaluated. According to the current evidence, the government should not allow the sales of e-cigarettes as consumer products in order to achieve the goal of smoking cessation.

 

Any government that adopts an e-cigarette smoking cessation strategy must regulate the conditions of product exposure to ensure proper clinical conditions and manage drug products (including requiring them to be distributed as pharmaceuticals). Even in such strict forms, the decision to pursue e-cigarettes as a means to achieve smoking cessation goals should only be made after reviewing domestic conditions, as well as examining smoking risks and proven cessation strategies.

 

Due to the growing prevalence of e-cigarette use, which has been found to have harmful effects on the health of children and adolescents, decisive action must be taken to prevent the use of e-cigarettes.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
UK-Listed Consumer Goods Group Supreme Sees Vape Duty as Potential Consolidation Opportunity, Holds FY27 Outlook
UK-Listed Consumer Goods Group Supreme Sees Vape Duty as Potential Consolidation Opportunity, Holds FY27 Outlook
UK-listed consumer goods group Supreme plc says it continues to expect FY27 trading to meet market expectations as the Vaping Products Duty takes effect on October 1, while maintaining a comparatively positive view of the new tax and compliance regime. Supreme has said the framework could increase compliance complexity for smaller operators and contribute to market consolidation, while its manufacturing, compliance and distribution scale may allow it to gain share. Its 88Vape brand will retain its value positioning.
Sep.18
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
Product | VAPORESSO Launches PRIX MTL Pod, With NFC Version Linking Interchangeable Panels to On-Screen Animations
Product | VAPORESSO Launches PRIX MTL Pod, With NFC Version Linking Interchangeable Panels to On-Screen Animations
VAPORESSO introduced the PRIX MTL pod system in August 2026 in two versions, Filter and NFC. The Filter version allows users to switch between a conventional drip tip and a filter tip, while the NFC version links interchangeable panels to matching on-screen animations. PRIX features a 2,600mAh battery, a 5.5ml pod, a 0.87-inch TFT display and a maximum output of 40W, alongside Dual Mesh Impact Pods capable of operating at two resistance and power configurations. VAPORESSO's French website lists MSRP at $39.99 for the Filter version and $49.90 for the NFC version.
Market
Aug.24 by 2Firsts Perspectives
EU Trade Department Faces Scrutiny Over Contacts With Tobacco Industry
EU Trade Department Faces Scrutiny Over Contacts With Tobacco Industry
European Ombudswoman Teresa Anjinho has opened an inquiry into how the European Commission’s Directorate-General for Trade handles interactions with the tobacco industry. The case follows a complaint from a civil society organisation that alleges regular, unnecessary and non-transparent contacts between DG TRADE and tobacco industry representatives, raising questions over compliance with the EU’s obligations under the WHO Framework Convention on Tobacco Control. The inquiry remains ongoing, and the Ombudswoman has not reached any finding of maladministration.
Aug.24
Product | JNR Launches Shisha Hookah 70K E-Hookah With 60ml E-Liquid and 0.6% Nicotine
Product | JNR Launches Shisha Hookah 70K E-Hookah With 60ml E-Liquid and 0.6% Nicotine
JNR has introduced the Shisha Hookah 70K, a high-capacity rechargeable disposable vape designed around a hookah-inspired experience. The device comes prefilled with 60ml of e-liquid at 6mg/ml (0.6%) nicotine strength, alongside a 1,000mAh rechargeable battery and a 0.38Ω single mesh coil. It also features adjustable airflow and battery and e-liquid level displays. JNR claims the device can deliver up to 70,000 puffs and offers more than 20 flavors. Retail listings for the product have appeared in markets including Tunisia.
Market
Aug.24 by 2Firsts Perspectives